{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-25-000024","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2025-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.878780+00:00","generated_at":"2026-05-26T13:49:35.013213+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeoGenomics Q4 revenue +11% to $172M; FY24 $661M; guides FY25 rev $735-745M","bullets":["Q4 consolidated revenue $172M (up 11% YoY); net loss $15M vs $14M in Q4 2023.","FY24 consolidated revenue $661M (+12% YoY); net loss $79M (improved from $88M).","Adjusted EBITDA FY24 positive $40M vs $3M in 2023, a 1,036% increase.","FY2025 guidance: revenue $735-745M (11-13% growth); adjusted EBITDA $55-58M.","Ninth consecutive quarter of double-digit revenue growth; NGS grew 34% in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-25-000024","json":"https://secwatch.observer/filing/0001077183-25-000024.json","markdown":"https://secwatch.observer/filing/0001077183-25-000024.md","text":"https://secwatch.observer/filing/0001077183-25-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000024/0001077183-25-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000024/neo-20250218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T13:49:35.013213+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}